source
- Dana-Farber and Beth Israel Lahey Health break ground on $1.68 billion cancer hospital in BostonOfficials from Dana-Farber Cancer Institute and Beth Israel Lahey Health announced the start of construction on a new dedicated cancer hospital in Boston's Longwood area. The project is budgeted at…
- Gilead’s oral ulcerative colitis drug shows significant remission in Phase 2 trialGilead Sciences reported results from a Phase 2 trial of its oral ulcerative colitis drug emvistegrast. In the study, patients took a 200 mg daily dose for 12 weeks and achieved a 23% placebo-adju…